Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Porter

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Oncogene|October 1, 1994
High frequency of mutator phenotype in human prostatic adenocarcinomaX Gao, N Wu, D Grignon, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 1998
Radiation therapy for endometrial cancer in patients treated for postoperative recurrenceK B Hart, I Han, F Shamsa, et al.
Urology|June 3, 1998
Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapyM K Garg, S Tekyi-Mensah, S Bolton, et al.
International Journal of Cancer|November 5, 1997
Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acidsD G Tang, K L Guan, L Li, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC alphaB Liu, R J Maher, J P De Jonckheere, et al.
Urology|October 1, 1996
Recommendations of the first Michigan conference on prostate cancerA T Porter, J Zimmerman, M Ruffin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to boneV J Lewington, A J McEwan, D M Ackery, et al.
The Journal of Urology|February 18, 1999
Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR)E Ben-Josef, S Y Yang, T H Ji, et al.
Urology|October 1, 1994
The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancerE D Crawford, J M Kozlowski, F M Debruyne, et al.
Cancer Research|September 15, 1999
Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chainB Joshi, L Li, B G Taffe, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Oncogene|October 1, 1994
High frequency of mutator phenotype in human prostatic adenocarcinomaX Gao, N Wu, D Grignon, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 1998
Radiation therapy for endometrial cancer in patients treated for postoperative recurrenceK B Hart, I Han, F Shamsa, et al.
Urology|June 3, 1998
Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapyM K Garg, S Tekyi-Mensah, S Bolton, et al.
International Journal of Cancer|November 5, 1997
Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acidsD G Tang, K L Guan, L Li, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC alphaB Liu, R J Maher, J P De Jonckheere, et al.
Urology|October 1, 1996
Recommendations of the first Michigan conference on prostate cancerA T Porter, J Zimmerman, M Ruffin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to boneV J Lewington, A J McEwan, D M Ackery, et al.
The Journal of Urology|February 18, 1999
Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR)E Ben-Josef, S Y Yang, T H Ji, et al.
Urology|October 1, 1994
The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancerE D Crawford, J M Kozlowski, F M Debruyne, et al.
Cancer Research|September 15, 1999
Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chainB Joshi, L Li, B G Taffe, et al.
Pageof 12